Low-event-rate meta-analyses of clinical trials: Implementing good practices

Statistics in Medicine

Volumn 35, Issue 14, 2016, Pages 2467-2478

  Shuster, Jonathan J ^a   Walker, Michael A ^b  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF IOWA   (United States)

Author keywords

Clinical trial; Low event rates; Meta analysis; Random effects; Relative risk

Indexed keywords

ROSIGLITAZONE; 2,4 THIAZOLIDINEDIONE DERIVATIVE; ANTIDIABETIC AGENT;

ARTICLE; BINOMIAL DISTRIBUTION; BIOSTATISTICS; CARDIOVASCULAR RISK; CONFIDENCE INTERVAL; COVARIANCE; HEALTH CARE POLICY; HEART INFARCTION; HUMAN; INTERMETHOD COMPARISON; INVERSE VARIANCE METHOD; LOW EVENT RATE; META ANALYSIS (TOPIC); NON INSULIN DEPENDENT DIABETES MELLITUS; ODDS RATIO; RANDOM EFFECT METHOD; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK FACTOR; SAMPLE SIZE; SAMPLING BIAS; SAMPLING ERROR; STATISTICAL ANALYSIS; CARDIOVASCULAR DISEASE; CLINICAL TRIAL (TOPIC); RISK; STATISTICAL MODEL; STATISTICS AND NUMERICAL DATA;

BIOSTATISTICS; CARDIOVASCULAR DISEASES; CLINICAL TRIALS AS TOPIC; DIABETES MELLITUS, TYPE 2; HUMANS; HYPOGLYCEMIC AGENTS; META-ANALYSIS AS TOPIC; MODELS, STATISTICAL; RISK; RISK FACTORS; THIAZOLIDINEDIONES;

EID: 84953240629     PISSN: 02776715     EISSN: 10970258     Source Type: Journal    
DOI: 10.1002/sim.6844     Document Type: Article

References (37)

1. Shuster JJ, Guo JD, Skyler JS. Meta-analysis of safety for low event-rate binomial trials. Research Synthesis Methods 2012; 3:30-50.
2. DerSimonian R, Laird N. Meta-analysis in clinical trials. Controlled Clinical Trials 1986; 7(3):177-188.
3. Higgins JPT, Green S (eds). Cochrane Handbook for Systematic Reviews for Interventions, Version 5.1.0. 2011; Wiley Publication, Chichester, UK.
4. Borenstein M, Hedges L, Higgins J, Rothstein H. Introduction to Meta-Analysis. Wiley: Chichester, UK, 2009.
5. Nissen SE, Wolski K. Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes. The New England Journal of Medicine 2007; 356(24):2457-2471.
6. Kishimoto T, Robenzadeh A, Leucht C, Leucht S, Watanabe K, Mimura M, Borenstein M, Kane JM, Correll CU. Long-acting injectable vs oral antipsychotics for relapse prevention in schizophrenia: a meta-analysis of randomized trials. Schizophrenia Bulletin 2014; 40(1):192-213.
7. Williams CJM, Peyrin-Biroulet L, Ford AC. Systematic review with meta-analysis: malignancies with anti-tumour necrosis factor-α therapy in inflammatory bowel disease. Alimentary Pharmacology and Therapeutics 2014; 39:447-458.
8. Monami M, Dicembrini I, Mannucci E. Dipeptidyl peptidase-4 inhibitors and pancreatitis risk: a meta-analysis of randomized clinical trials. Diabetes, Obesity, and Metabolism 2014; 16:48-56.
9. Böhning D, Malzahn U, Dietz E, Schlattmann P. Some general points in estimating heterogeneity variance with the DerSimonian-Laird estimator. Biostatistics 2002; 3:445-457.
10. Hamza TH, van Houwelingen HC, Stijnen T. The binomial distribution of meta-analysis was preferred to model within-study variability. Journal of Clinical Epidemiology 2008; 61:41-51.
11. Shuster JJ, Jones LS, Salmon DA. Fixed vs random effects meta-analysis in rare event studies: the rosiglitazone link with myocardial infarction and cardiac death. Statistics in Medicine 2007; 26(24):4375-4385.
12. Shuster JJ. Nonparametric optimality of the sample mean and sample variance. American Statistician 1982; 36:176-178.
13. Bridge JA, Iyengar S, Salary CB, Barbe RP, Birmaher B, Pincus HA, Ren L, Brent DA. Clinical response and risk for reported suicidal ideation and suicide attempts in pediatric antidepressant treatment: a meta-analysis of randomized controlled trials. JAMA 2007; 297(15):1683-1696. PubMed PMID: 17440145.
14. Hempel S, Newberry SJ, Maher AR, Wang Z, Miles JN, Shanman R, Johnsen B, Shekelle PG. Probiotics for the prevention and treatment of antibiotic-associated diarrhea: a systematic review and meta-analysis. JAMA 2012; 307(18):1959-1969.
15. Kayentao K, Garner P, van Eijk AM, Naidoo I, Roper C, Mulokozi A, MacArthur JR, Luntamo M, Ashorn P, Doumbo OK, ter Kuile FO. Intermittent preventive therapy for malaria during pregnancy using 2 vs 3 or more doses of sulfadoxine-pyrimethamine and risk of low birth weight in Africa: systematic review and meta-analysis. JAMA 2013; 309(6):594-604.
16. Nalluri SR, Chu D, Keresztes R, Zhu X, Wu S. Risk of venous thromboembolism with the angiogenesis inhibitor bevacizumab in cancer patients: a meta-analysis. JAMA 2008; 300(19):2277-2285.
17. Neto AS, Cardosa SO, Manetta JA, Pereira VG, Espósito DC, Pasqualucci Mde O, Damasceno MC, Schultz MJ. Association between use of lung-protective ventilation with lower tidal volumes and clinical outcomes among patients without acute respiratory distress syndrome: a meta-analysis. JAMA 2012; 308(16):1651-1659.
18. Nguyen PL, Je Y, Schutz FA, Hoffman KE, Hu JC, Parekh A, Beckman JA, Choueiri TK. Association of androgen deprivation therapy with cardiovascular death in patients with prostate cancer: a meta-analysis of randomized trials. JAMA 2011; 306(21):2359-2366.
19. Preiss D, Tikkanen MJ, Welsh P, Ford I, Lovato LC, Elam MB, LaRosa JC, DeMicco DA, Colhoun HM, Goldenberg I, Murphy MJ, MacDonald TM, Pedersen TR, Keech AC, Ridker PM, Kjekshus J, Sattar N, McMurray JJ. Lipid-modifying therapies and risk of pancreatitis: a meta-analysis. JAMA 2012; 308(8):804-811.
20. Ranpura V, Hapani S, Wu S. Treatment-related mortality with bevacizumab in cancer patients: a meta-analysis. JAMA 2011; 305(5):487-494 (Corrected JAMA.2011; 305 (8): 229-229, not relevant to exercise in this paper).
21. Rizos EC, Ntzani EE, Bika E, Kostapanos MS, Elisaf MS. Association between omega-3 fatty acid supplementation and risk of major cardiovascular disease events: a systematic review and meta-analysis. JAMA 2012; 308(10):1024-1033.
22. Singh S, Loke YK, Furberg CD. Inhaled anticholinergic and risk of major adverse cardiovascular events in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis. JAMA 2008; 300(12):1439-1450.
23. Udell JA, Zawi R, Bhatt DL, Keshtkar-Jahromi M, Gaughran F, Phrommintikul A, Ciszewski A, Vakili H, Hoffman EB, Farkouh ME, Cannon CP. Association between influenza vaccination and cardiovascular outcomes in high-risk patients: a meta-analysis. JAMA 2013; 310(16):1711-1720.
24. Wiener RS, Wiener DC, Larson RJ. Benefits and risks of tight glucose control in critically ill adults: a meta-analysis. JAMA 2008; 300(8):933-944. (Corrected JAMA.2009; 301(9): 936-936, not relevant to exercise in this paper).
25. Zarychanski R, Abou-Setta AM, Turgeon AF, Houston BL, McIntyre L, Marshall JC, Fergusson DA. Association of hydroxyethyl starch administration with mortality and acute kidney injury in critically ill patients requiring volume resuscitation: a systematic review and meta-analysis. JAMA 2013; 309(7):678-688.
26. Diamond GA, Kaul S. Rosiglitazone and cardiovascular risk. New England Journal of Medicine 2007; 357(9):938-939.
27. Nissen SE, Wolski K. Rosiglitazone revisited: an updated meta-analysis for myocardial infarction and cardiovascular mortality. Archives of Internal Medicine 2010; 170(14):1191-1201.
28. Shuster JJ. Empirical vs natural weighting in random effects meta-analysis. Statistics in Medicine 2010; 29(12):1259-1265.
29. Laird N, Fitzmaurice G, Ding X. Comments on 'Empirical vs natural weighting in random effects meta-analysis'. Statistics in Medicine 2010; 29(12):1266-1267.
30. Waksman JA. Comments on 'Empirical vs natural weighting in random effects meta-analysis'. Statistics in Medicine 2010; 29(12):1268-1269.
31. Thompson SG, Higgins JPT. Comments on 'Empirical vs natural weighting in random effects meta-analysis'. Statistics in Medicine 2010; 29(12):1270-1271.
32. Shuster JJ, Hatton RC, Hendeles L, Winterstein AG. Reply to discussion of 'Empirical vs natural weighting in random effects meta-analysis'. Statistics in Medicine 2010; 29(12):1272-1281.
33. Stijnen T, Hamza TH, Ozdemir P. Random effects meta-analysis of event outcome in the framework of the generalized linear mixed model with applications in sparse data. Statistics in Medicine 2010; 29:3046-3067.
34. Tian L, Cai T, Pfeffer MA, Piankov N, Cremieux PY, Wei LJ. Exact and efficient inference procedure for meta-analysis and its application to the analysis of independent 2 x 2 tables with all available data but without artificial continuity correction. Biostatistics 2009; 10(2):275-281.
35. Lane PW. Meta-analysis of incidence of rare events. Statistical Methods in Medical Research 2013; 22(2):117-132.
36. Kuss O. Statistical methods for meta-analyses including information from studies without any events-add nothing to nothing and succeed nevertheless. Statistics in Medicine 2015; 34(7):1097-1116.
37. Cornell JE, Mulrow CD, Localio R, Stack CB, Melbohm AR, Guallar E, Goodman SN. Random-effects meta-analysis of inconsistent effects: a time for change. Annals of Internal Medicine 2014; 160(4):267-270.